SAFETY OF LINACLOTIDE IN PEDIATRIC PATIENTS WITH FUNCTIONAL CONSTIPATION: A POOLED ANALYSIS OF PLACEBO-CONTROLLED RANDOMIZED-CONTROLLED TRIALS

被引：0
|
作者：
Hyams, Jeffrey S.
Saps, Miguel
Di Lorenzo, Carlo
Rodriguez-Araujo, Gerardo
Xie, Wangang
Huh, Susanna Y.
Weissman, Darren
Khlevner, Julie
Nurko, Samuel
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo2015
引用
收藏
页码：S954 / S954
页数：1
相关论文
共 50 条
  • [31] A POOLED ANALYSIS OF FALL INCIDENCE FROM PLACEBO-CONTROLLED TRIALS OF DENOSUMAB
    McCloskey, E. V.
    Eastell, R.
    Mcclung, M.
    Pannacciulli, N.
    Wang, C.
    Yue, S.
    Cummings, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S179 - S180
  • [32] Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials
    Ting Liu
    Faping Wang
    Geng Wang
    Hui Mao
    Frontiers of Medicine, 2018, 12 : 340 - 349
  • [33] Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials
    Liu, Ting
    Wang, Faping
    Wang, Geng
    Mao, Hui
    FRONTIERS OF MEDICINE, 2018, 12 (03) : 340 - 349
  • [34] Safety of Linagliptin in 8,778 Patients with Type 2 Diabetes Mellitus: Pooled Analysis of 23 Placebo-Controlled, Randomized Clinical Trials
    Schernthaner, Guntram
    Khunti, Kamlesh
    Patel, Sanjay
    Cheng, Karen
    Mattheus, Michaela
    Woerle, Hans-Juergen
    DIABETES, 2014, 63 : A281 - A281
  • [35] Cardiovascular safety of eptinezumab: A pooled analysis of double-blind, randomized, placebo-controlled studies
    Smith, T. R.
    Spierings, E. L. H.
    Cady, R.
    Hirman, J.
    Ettrup, A.
    Shen, V
    HEADACHE, 2021, 61 : 112 - 112
  • [36] Two randomized double-blind, placebo-controlled phase 3 trials of linaclotide in patients with chronic constipation: effects on quality of life among patients with abdominal symptoms
    Carson, R.
    Tourkodimitris, S.
    Lewis, B. E.
    Johnston, J. M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 : 29 - 29
  • [37] POOLED SAFETY AND ADVERSE EVENTS IN NINE RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 AND 3 CLINICAL TRIALS OF ALIROCUMAB
    Jones, Peter H.
    Bays, Harold
    Chaudhari, Umesh
    Pordy, Robert
    Lorenzato, Christelle
    Miller, Kathryn
    Robinson, Jennifer
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1363 - A1363
  • [38] Low molecular weight heparin in hospitalized cancer patients: a systematic review and pooled analysis of placebo-controlled randomized trials
    Carrier, M.
    Moretto, P.
    Khorana, A.
    Le Gal, G.
    Zwicker, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 858 - 858
  • [39] Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials
    Schoenfeld, P.
    Pimentel, M.
    Chang, L.
    Lembo, A.
    Chey, W. D.
    Yu, J.
    Paterson, C.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1161 - 1168
  • [40] Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials
    Tuttle, Katherine R.
    Levin, Adeera
    Nangaku, Masaomi
    Kadowaki, Takashi
    Agarwal, Rajiv
    Hauske, Sibylle J.
    Elsasser, Amelie
    Ritter, Ivana
    Steubl, Dominik
    Wanner, Christoph
    Wheeler, David C.
    DIABETES CARE, 2022, 45 (06) : 1445 - 1452
12345